Global markets are balancing ongoing geopolitical anxiety surrounding the Strait of Hormuz against a wave of aggressive corporate consolidation and sector-specific volatility. Crude oil and European natural gas prices are ticking higher as Iran tempers expectations for a swift reopening of the critical waterway, driving uncertainty that persists ahead of upcoming U.S. inflation data. Amidst this climate, substantial dealmaking is defining the corporate landscape, highlighted by Teledyne Technologies’ $1.1 billion cash acquisition of Varex Imaging, Bernhard’s $1 billion buyout of Bowman Consulting, and Safe Harbor’s agreement to acquire MarineMax. Tech markets are reacting to conflicting signals: while hardware stocks are seeing renewed interest due to 'chipflation,' Apple faced a rating downgrade from Jefferies following reports that plans for a higher-priced all-glass iPhone model were canceled. In the industrial and energy policy sectors, new U.S. solar tariffs aim to support domestic manufacturing—potentially at the cost of higher installation prices—while industry-backed PACs continue to target politicians hostile to renewable energy projects. Meanwhile, the healthcare sector saw extreme dispersion in market performance, with AbCellera shares surging on positive trial results, whereas Sionna Therapeutics and Tenax Therapeutics faced dramatic share price collapses after failing clinical trial endpoints. On the periphery of official discourse, the Pentagon’s continued, rolling declassification of documents regarding unidentified anomalous phenomena has triggered a spike in reporting and public interest, notably in Germany.